ES2094034T3 - Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion. - Google Patents
Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion.Info
- Publication number
- ES2094034T3 ES2094034T3 ES94402895T ES94402895T ES2094034T3 ES 2094034 T3 ES2094034 T3 ES 2094034T3 ES 94402895 T ES94402895 T ES 94402895T ES 94402895 T ES94402895 T ES 94402895T ES 2094034 T3 ES2094034 T3 ES 2094034T3
- Authority
- ES
- Spain
- Prior art keywords
- deep
- composition
- simultaneous treatment
- skin
- acneic
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/36—Carboxylic acids; Salts or anhydrides thereof
- A61K8/368—Carboxylic acids; Salts or anhydrides thereof with carboxyl groups directly bound to carbon atoms of aromatic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
- A61K8/14—Liposomes; Vesicles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
- A61K8/347—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/67—Vitamins
- A61K8/671—Vitamin A; Derivatives thereof, e.g. ester of vitamin A acid, ester of retinol, retinol, retinal
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/127—Liposomes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/12—Keratolytics, e.g. wart or anti-corn preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/18—Antioxidants, e.g. antiradicals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Chemical & Material Sciences (AREA)
- Birds (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Emergency Medicine (AREA)
- Dermatology (AREA)
- Engineering & Computer Science (AREA)
- Dispersion Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Oncology (AREA)
- Biochemistry (AREA)
- Rheumatology (AREA)
- Communicable Diseases (AREA)
- Pain & Pain Management (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
LA COMPOSICION ANTIACNEICA DE LA INVENCION PARA EL TRATAMIENTO SIMULTANEO DE LAS CAPAS SUPERFICIALES Y PROFUNDAS DE LA PIEL, COMPRENDE UNA PRIMERA DISPERSION DE VESICULAS LIPIDICAS APTAS PARA PENETRAS EN LAS CAPAS PROFUNDAS DE LA PIEL Y QUE CONTIENE AL MENOS UN ACTIVO ELEGIDO ENTRE LOS AGENTES ANTIMICROBIANOS, ANTISEPTICOS, ANTIBIOTICOS, ANTIINFLAMATORIOS, ANTISEBORREICOS, EL RETINOL Y SUS DERIVADOS PARA TRATAR ESTAS CAPAS PROFUNDAS Y UNA SEGUNDA DISPERSION DE VESICULAS LIPIDICAS APTAS PARA PENETRAR EN LAS CAPAS SUPERFICIALES DE LA PIEL Y QUE CONTIENE AL MENOS UN ACTIVO ELEGIDO ENTRE LOS AGENTES QUERATOLITICOS, PROTECTORES, HIDRATANTES Y ANTIOXIDANTES PARA TRATAR ESTAS CAPAS SUPERFICIALES.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
FR9315865A FR2714602B1 (fr) | 1993-12-30 | 1993-12-30 | Composition antiacnéique pour le traitement simultané des couches superficielles et profondes de la peau, son utilisation. |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2094034T3 true ES2094034T3 (es) | 1997-01-01 |
Family
ID=9454568
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES94402895T Expired - Lifetime ES2094034T3 (es) | 1993-12-30 | 1994-12-15 | Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion. |
Country Status (12)
Country | Link |
---|---|
US (1) | US5679374A (es) |
EP (1) | EP0661036B1 (es) |
JP (1) | JP2714541B2 (es) |
AT (1) | ATE141781T1 (es) |
BR (1) | BR9405482A (es) |
CA (1) | CA2138873C (es) |
DE (1) | DE69400428T2 (es) |
ES (1) | ES2094034T3 (es) |
FR (1) | FR2714602B1 (es) |
HU (1) | HUT71722A (es) |
PL (1) | PL306586A1 (es) |
RU (1) | RU2128506C1 (es) |
Families Citing this family (67)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5648389A (en) * | 1995-10-27 | 1997-07-15 | Medicis Pharmaceutical, Inc. | Compositions for the treatment of dermatological disorders and methods for their use |
DE19540749A1 (de) * | 1995-11-02 | 1997-05-07 | Beiersdorf Ag | Kosmetische Zubereitungen mit einem wirksamen Gehalt an Glycosylglyceriden |
US6183774B1 (en) | 1996-01-31 | 2001-02-06 | Collaborative Laboratories, Inc. | Stabilizing vitamin A derivatives by encapsulation in lipid vesicles formed with alkylammonium fatty acid salts |
AUPN814496A0 (en) * | 1996-02-19 | 1996-03-14 | Monash University | Dermal penetration enhancer |
US7094422B2 (en) * | 1996-02-19 | 2006-08-22 | Acrux Dds Pty Ltd. | Topical delivery of antifungal agents |
FR2750049B1 (fr) * | 1996-06-21 | 1998-07-31 | Oreal | Nouveau procede de preparation de compositions uv-filtrantes compositions susceptibles d'etre obtenues par ce procede et applications |
US8039026B1 (en) | 1997-07-28 | 2011-10-18 | Johnson & Johnson Consumer Companies, Inc | Methods for treating skin pigmentation |
FR2768053B1 (fr) * | 1997-09-09 | 1999-10-15 | Oreal | Compositions photoprotectrices comprenant un benzylidene camphre et/ou un dibenzoylmethane et/ou une triazine et un tartrate de dialkyle; utilisations en cosmetique |
IL122084A (en) * | 1997-10-31 | 1999-09-22 | Lurident Ltd | Formulation for personal care with mucoadhesive properties |
US6042841A (en) * | 1998-03-16 | 2000-03-28 | Unilever Home & Personal Care Usa Division Of Conopco, Inc. | Cosmetic method of treating skin |
US6022896A (en) * | 1998-09-10 | 2000-02-08 | Chesebrough-Pond's Usa Co. | Petroselinic acid as an anti-irritant in compositions containing alpha-hydroxy acids |
US8106094B2 (en) | 1998-07-06 | 2012-01-31 | Johnson & Johnson Consumer Companies, Inc. | Compositions and methods for treating skin conditions |
US6750229B2 (en) | 1998-07-06 | 2004-06-15 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin pigmentation |
US8093293B2 (en) | 1998-07-06 | 2012-01-10 | Johnson & Johnson Consumer Companies, Inc. | Methods for treating skin conditions |
US6521237B2 (en) | 1998-11-12 | 2003-02-18 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
US7396526B1 (en) | 1998-11-12 | 2008-07-08 | Johnson & Johnson Consumer Companies, Inc. | Skin care composition |
US6444647B1 (en) | 1999-04-19 | 2002-09-03 | The Procter & Gamble Company | Skin care compositions containing combination of skin care actives |
US7985404B1 (en) | 1999-07-27 | 2011-07-26 | Johnson & Johnson Consumer Companies, Inc. | Reducing hair growth, hair follicle and hair shaft size and hair pigmentation |
US7309688B2 (en) | 2000-10-27 | 2007-12-18 | Johnson & Johnson Consumer Companies | Topical anti-cancer compositions and methods of use thereof |
US6861060B1 (en) | 2000-04-21 | 2005-03-01 | Elena Luriya | Personal care formulations |
AU2001261206A1 (en) * | 2000-05-05 | 2001-11-20 | Johnson And Johnson Consumer Companies, Inc. | Skin care composition |
US20020153508A1 (en) * | 2000-06-29 | 2002-10-24 | Lynch Matthew Lawrence | Cubic liquid crystalline compositions and methods for their preparation |
KR20020027198A (ko) * | 2000-10-02 | 2002-04-13 | 차알스 제이. 메츠 | 염증과 홍반의 완화방법 |
US20040213754A1 (en) * | 2000-10-02 | 2004-10-28 | Cole Curtis A. | Method for cleansing sensitive skin using an alkanolamine |
US8431550B2 (en) | 2000-10-27 | 2013-04-30 | Johnson & Johnson Consumer Companies, Inc. | Topical anti-cancer compositions and methods of use thereof |
US6555143B2 (en) | 2001-02-28 | 2003-04-29 | Johnson & Johnson Consumer Products, Inc. | Legume products |
US7192615B2 (en) | 2001-02-28 | 2007-03-20 | J&J Consumer Companies, Inc. | Compositions containing legume products |
CA2446356C (en) * | 2001-05-09 | 2012-07-10 | The Regents Of The University Of Michigan | Use of compositions for treating rosacea |
US20050238730A1 (en) * | 2001-11-21 | 2005-10-27 | Agnes Le Fur | Compositions comprising an ethanolamine derivative and organic metal salts |
US20110142922A1 (en) * | 2002-04-30 | 2011-06-16 | Ferndale Ip, Inc. | Stabilized composition and method for dermatological treatment |
DE50211163D1 (de) * | 2002-04-30 | 2007-12-20 | Cognis Ip Man Gmbh | Mikrokapseln mit Anti-Aknewirkstoffen |
US20030215493A1 (en) * | 2002-04-30 | 2003-11-20 | Patel Pravin M. | Composition and method for dermatological treatment |
EP1358872B1 (de) * | 2002-04-30 | 2008-03-12 | Cognis IP Management GmbH | Verwendung von Wirkstoffmischungen mit Azelainsäure und Glycyrrhetinsäure als Anti-Aknemittel |
US20030232091A1 (en) * | 2002-06-17 | 2003-12-18 | Adi Shefer | Stabilized retinol for cosmetic dermatological, and pharmaceutical compositions, and use thereof |
DE10232774B4 (de) * | 2002-07-18 | 2004-07-15 | Cognis Deutschland Gmbh & Co. Kg | Kosmetische Zubereitungen mit antibakteriellen Eigenschaften |
FR2843125B1 (fr) * | 2002-08-02 | 2012-11-16 | Coletica | Principes actifs stimulant les beta-defensives humaines de type 2 et/ou de type 3, et compositions cosmetiques ou pharmaceutiques comprenant de tels principes actifs |
EP1449533A1 (en) * | 2003-02-24 | 2004-08-25 | Euro-Celtique S.A. | Use of PVP-iodine liposomes for the treatment of acne |
US20080076720A1 (en) * | 2003-03-04 | 2008-03-27 | Sancai Xie | Personal care compositions having kinetin or zeatin |
US20040175347A1 (en) * | 2003-03-04 | 2004-09-09 | The Procter & Gamble Company | Regulation of mammalian keratinous tissue using hexamidine compositions |
US7285570B2 (en) * | 2003-04-17 | 2007-10-23 | The Procter & Gamble Company | Compositions and methods for regulating mammalian keratinous tissue |
CA2529953A1 (en) * | 2003-06-23 | 2004-12-29 | Transpharma Medical Ltd. | Transdermal delivery system for cosmetic agents |
US20060018852A1 (en) | 2003-08-22 | 2006-01-26 | L'oreal | Compositions containing topical active agents and pentylene glycol |
US20050043283A1 (en) * | 2003-08-22 | 2005-02-24 | L'oreal S.A. | Compositions containing topical active agents and pentylene glycol |
US7416756B2 (en) * | 2003-09-10 | 2008-08-26 | Eastman Chemical Company | Process for the recovery of a phytolipid composition |
US7285544B2 (en) * | 2003-11-18 | 2007-10-23 | Bernstein Eric F | Use of nitroxides in treating skin disease |
US8053000B2 (en) * | 2005-06-07 | 2011-11-08 | Dr. Reddy's Laboratories Limited | Compositions for drug delivery |
BRPI0617809A2 (pt) * | 2005-10-24 | 2011-08-09 | Ciba Holding Inc | proteção de agentes oxidáveis |
US20070128137A1 (en) * | 2005-12-02 | 2007-06-07 | Naohisa Yoshimi | Water in oil emulsion compositions containing siloxane elastomers |
DE102006004804A1 (de) | 2006-01-23 | 2007-07-26 | Intendis Gmbh | Verwendung von Alkandicarbonsäuren und Retinoiden zur Behandlung entzündlicher Hauterkrankungen |
US20070203040A1 (en) * | 2006-02-24 | 2007-08-30 | Harry Reicherz | Bar soap |
US7252816B1 (en) * | 2006-03-29 | 2007-08-07 | Dow Pharmaceutical Sciences | Topical acne vulgairs medication with a sunscreen |
DE102006015271A1 (de) * | 2006-04-01 | 2007-10-11 | Lohmann & Rauscher Gmbh & Co. Kg | Biguanidhaltige Liposomen |
WO2007133768A2 (en) * | 2006-05-15 | 2007-11-22 | The Procter & Gamble Company | Method of enhancing penetration of water-soluble actives |
US20070274932A1 (en) * | 2006-05-15 | 2007-11-29 | The Procter & Gamble Company | Water in oil emulsion compositions containing sunscreen actives and siloxane elastomers |
US8604901B2 (en) * | 2006-06-27 | 2013-12-10 | Eyelock, Inc. | Ensuring the provenance of passengers at a transportation facility |
KR100752990B1 (ko) * | 2006-08-02 | 2007-08-30 | 주식회사 대웅 | 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물 |
US20090137534A1 (en) * | 2007-11-26 | 2009-05-28 | Chaudhuri Ratan K | Skin treatment compositions and methods |
US20090011035A1 (en) * | 2007-07-03 | 2009-01-08 | Joseph Michael Zukowski | Personal care composition |
US20090041686A1 (en) * | 2007-08-06 | 2009-02-12 | Osborne David W | Topical acne vulgaris composition with a sunscreen |
PL2187736T3 (pl) | 2007-08-16 | 2016-01-29 | Univ Chicago | Odporność na patogeny roślin |
FR2947172B1 (fr) * | 2009-06-29 | 2011-09-09 | Natura Cosmeticos Sa | Composition cosmetique, kit de traitement de la peau, procede pour traiter les peaux grasses, mixtes ou acneiques |
KR101443927B1 (ko) | 2009-08-20 | 2014-09-25 | (주)아모레퍼시픽 | 헥사미딘류 및 레티노이드류를 함유하는 피부 개선 조성물 |
US20110070174A1 (en) * | 2009-09-21 | 2011-03-24 | PruGen IP Holdings, Inc. | Benzoyl Peroxide and Sunscreen Agent Combination |
RU2485955C2 (ru) * | 2010-11-17 | 2013-06-27 | Леонид Леонидович Клопотенко | Фармацевтическая композиция, содержащая флуконазол, и/или кетоконазол, и/или тербинафин и липосомы для местного применения |
CN102366407B (zh) * | 2011-09-14 | 2013-03-20 | 海南灵康制药有限公司 | 盐酸克林霉素棕榈酸酯脂质体固体制剂 |
WO2019089942A1 (en) * | 2017-11-02 | 2019-05-09 | Rick Coulon | Formulations for use in the transdermal delivery of proteasome inhibitors |
GB201906362D0 (en) * | 2019-05-06 | 2019-06-19 | Givaudan Sa | Cosmetic ingredient |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4217344A (en) * | 1976-06-23 | 1980-08-12 | L'oreal | Compositions containing aqueous dispersions of lipid spheres |
EP0571063A1 (de) * | 1989-12-14 | 1993-11-24 | Schering Aktiengesellschaft | Pharmazeutische Präparate |
-
1993
- 1993-12-30 FR FR9315865A patent/FR2714602B1/fr not_active Expired - Fee Related
-
1994
- 1994-12-15 EP EP94402895A patent/EP0661036B1/fr not_active Expired - Lifetime
- 1994-12-15 DE DE69400428T patent/DE69400428T2/de not_active Expired - Lifetime
- 1994-12-15 ES ES94402895T patent/ES2094034T3/es not_active Expired - Lifetime
- 1994-12-15 AT AT94402895T patent/ATE141781T1/de active
- 1994-12-22 CA CA002138873A patent/CA2138873C/fr not_active Expired - Fee Related
- 1994-12-27 JP JP6326411A patent/JP2714541B2/ja not_active Expired - Fee Related
- 1994-12-29 RU RU94045285A patent/RU2128506C1/ru not_active IP Right Cessation
- 1994-12-29 HU HU9403821A patent/HUT71722A/hu unknown
- 1994-12-29 BR BR9405482A patent/BR9405482A/pt not_active Application Discontinuation
- 1994-12-29 PL PL94306586A patent/PL306586A1/xx unknown
- 1994-12-30 US US08/367,422 patent/US5679374A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
ATE141781T1 (de) | 1996-09-15 |
DE69400428T2 (de) | 1997-01-16 |
PL306586A1 (en) | 1995-07-10 |
CA2138873C (fr) | 1999-12-14 |
JPH07309781A (ja) | 1995-11-28 |
CA2138873A1 (fr) | 1995-07-01 |
EP0661036A1 (fr) | 1995-07-05 |
FR2714602A1 (fr) | 1995-07-07 |
HU9403821D0 (en) | 1995-03-28 |
FR2714602B1 (fr) | 1996-02-09 |
HUT71722A (en) | 1996-01-29 |
US5679374A (en) | 1997-10-21 |
DE69400428D1 (de) | 1996-10-02 |
RU94045285A (ru) | 1996-11-10 |
RU2128506C1 (ru) | 1999-04-10 |
BR9405482A (pt) | 1995-09-19 |
JP2714541B2 (ja) | 1998-02-16 |
EP0661036B1 (fr) | 1996-08-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2094034T3 (es) | Composicion antiacneica para el tratamiento simultaneo de las capas superficiales y profundas de la piel, su utilizacion. | |
ES2092876T3 (es) | Composicion despigmentante para el tratamiento simultaneo de las capas superficiales y profundas de la piel. | |
ES2092386T3 (es) | Composicion para combatir el envejecimiento, que actua sobre las capas superficiales y profundas de la piel, su utilizacion. | |
ES2095731T3 (es) | Composicion adelgazante con dos tipos de liposomas para tratamiento topico, su utilizacion. | |
ES2154336T3 (es) | Producto para el cuidado de la piel. | |
GR1002807B (el) | Συστημα για την τοπικη θεραπεια της ακμης και μεθοδος παραγωγης του | |
AR042345A2 (es) | Un procedimiento para la preparacion de una composicion farmaceutica para el tratamiento de aterosclerosis que contiene 8.9 - dehidroesterona o sus sales de la misma | |
BR9611587A (pt) | Processo e composição para tratamento da pele deseres humanos e preparação tópica para aplicação à pele. | |
ES2124328T3 (es) | Liposomas que contienen diacetato de clorhexidina o digluconato de clorhexidina. | |
CA2202137A1 (en) | Composition, device and method for enhanced electrotransport agent delivery | |
ES2108698T3 (es) | Liposomas exentos de sustancias activas, para el tratamiento de aterosclerosis. | |
AR025379A1 (es) | 9a-azalidas con actividad antibacteriana. | |
ATE173396T1 (de) | Spruehformulierung mit kuehleffekt | |
ES2120667T3 (es) | Sal de l-carnitina y composiciones cosmeticas y farmaceuticas que la contienen para tratamiento de dermatosis. | |
ES2091981T3 (es) | Procedimiento para la fabricacion de preparaciones de crema estables, hidrofilas o ambifilas, que contienen componentes vesiculares, asi como el uso de las mismas. | |
ES2176331T3 (es) | Uso de agentes inmunosupresores para el tratamiento de la esquizofrenia. | |
ES2157984T3 (es) | Utilizacion de 4'-yodo-4'-desoxidoxorrubicina para el tratamiento de la amidoidosis. | |
ES2196769T3 (es) | Uso topico de loperamide para el tratamiento de infecciones microbianas. | |
ES2184121T3 (es) | Formulacion para el tratamiento y/o profilaxis de la demencia. | |
DK0697885T3 (da) | Insulinlignende vækstfaktor II som antitumormiddel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG2A | Definitive protection |
Ref document number: 661036 Country of ref document: ES |